M. Alakloby, Omar
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
21.01.2021
Asclepion Laser Technologies: Innovative partner for your aesthetic practice
To develop innovative and successful products is the ethos of Asclepion Laser Technologies. Therefore, the company invests intensively in research and medical practice. The goal is to make the advantages […]
01.11.2016
Australian Medical Board issues guidelines on cosmetic medical and surgical procedures
The Medical Board of Australia has issued guidelines for medical practitioners who perform cosmetic medical and surgical procedures. ‘The guidelines will help keep patients safe, without imposing an […]